Irina Bykhovskaya, M.D.
Contributing Editor
Earlier this year at "Doheny Days", Dr. Bykhovskaya shared a unique case involving a large hemangioblastoma caused by Von Hippel-Lindau disease. VHL is a genetic disorder in which tumors arise in highly vascularized areas of the body resulting in angiomatoses, renal cell carcinomas, pancreatic tumors and pheochromocytomas. Eugene Von Hippel, MD first described these angiomas in the eye in 1904. Decades later, Avrid Lindau, MD found similar angiomas associated with nervous tissue. More than 100 years after its initial characterization, Dr. Bykhovskaya takes us through diagnosis and treatment of a VHL case using technology Von Hippel and Lindau could only have dreamed of (OCT, Tonopen, Volk lenses, photocoagulation systems, PDT with 693nm lasers and verteporfin). Take a look at the presentation below to brush up on the issues related to VHL. - Ed.
Have a question or comment on this article? Use the "Comment" link above to leave your thoughts, and the author will respond.